PUBLISHER: GlobalData | PRODUCT CODE: 1424873
PUBLISHER: GlobalData | PRODUCT CODE: 1424873
Exhalation Monitors Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 is built to visualize quantitative market trends within Patient Monitoring therapeutic area.
The model discusses in detail the impact of COVID-19 on the Exhalation Monitors market for the year 2020 and beyond. The prevalence of obstructive sleep apnea (OSA), associated with accompanying daytime sleepiness, is approximately 3% to 7% for adults in the general population. Generally, there is a lack of awareness of the diseases among both the medical community and the public. As a result, the majority of those who suffered remain undiagnosed. Disease prevalence is higher in different population subsets, including overweight or obese people and older individuals. It can be expected that with the increasing aging population and prevalence of obesity, the prevalence of OSA will be increasing in the future. Moreover, as prevalence estimates of obstructive sleep apnea from North America, Europe, and APAC are not substantially different, it suggests that OSA is common not only in developed but also in developing countries.
Among all types of exhalation monitors, respiratory monitoring device will be more likely to be affected. Home care usage of the devices, especially will be more prevalent. The devices will have immense market growth in developing economies. These emerging countries struggle deeply with respiratory illnesses and affordable methods for sufficient patient monitoring.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Exhalation Monitors and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Philips Healthcare, Medtronic Plc, Vyaire Medical Inc, Dragerwerk AG &Co KGaA, Pulmonx Corp and Others
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable